dronabinol has been researched along with Amnesia-Memory Loss in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Canela, EI; Cordomí, A; de La Torre, R; Gasperini, P; Howell, LA; Lanfumey, L; Lluís, C; Maldonado, R; McCormick, PJ; Moreno, E; Navarro, G; Pardo, L; Pastor, A; Robledo, P; Viñals, X | 1 |
Busquets-Garcia, A; Gomis-González, M; Maldonado, R; Marsicano, G; Ozaita, A; Puighermanal, E | 1 |
Braley, G; Cooper, T; D'Souza, DC; Gueorguieva, R; Krystal, J; Perry, E; Ranganathan, M; Zimolo, Z | 1 |
1 trial(s) available for dronabinol and Amnesia-Memory Loss
Article | Year |
---|---|
Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis.
Topics: Adolescent; Adult; Amnesia; Attention; Brain; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Administration Schedule; Drug Tolerance; Female; Hallucinations; Hallucinogens; Humans; Hydrocortisone; Male; Marijuana Abuse; Middle Aged; Perceptual Disorders; Prolactin; Psychoses, Substance-Induced; Tachycardia; Young Adult | 2008 |
2 other study(ies) available for dronabinol and Amnesia-Memory Loss
Article | Year |
---|---|
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors.
Topics: Amnesia; Analgesia; Animals; Anxiety; Brain; Cognition Disorders; Dimerization; Dorsal Raphe Nucleus; Dronabinol; HEK293 Cells; Humans; Hypothermia; Locomotion; Mice, Inbred C57BL; Mice, Transgenic; Receptor, Cannabinoid, CB1; Receptor, Serotonin, 5-HT2A | 2015 |
Dissociation of the pharmacological effects of THC by mTOR blockade.
Topics: Amnesia; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Brain; Down-Regulation; Dronabinol; Drug Interactions; Drug Tolerance; Hypothermia; Locomotion; Male; Mice; Mice, Knockout; Nociception; Receptor, Cannabinoid, CB1; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2013 |